Andreas Bender/Developing and applying novel data mining approaches of chemical and biological data, in drug discovery, chemical biology, and in silico toxicology/Reader at the Centre for Molecular Science Informatics of the University of Cambridge/Co-founder of Healx Ltd., for data-driven drug repurposing for rare diseases http://www.healx.io/Co-founder of PharmEnable Ltd., for accessing new chemistry for difficult targets http://www.pharmenable.com
Dear All, The programme for our Cambridge Cheminformatics Meeting has just been confirmed as follows,… Read More »Programme Online, Registration Open: Cambridge Cheminformatics Meeting, 2 September 2020 (on Zoom, open to all)
Dear All, I would like to circulate some current Cheminformatics (and -related) news to everyone… Read More »Cambridge Cheminformatics Newsletter, 7 August 2020
Iñigo Ayestaran is a first year PhD student at the Department of Oncology at the… Read More »Identification of Intrinsic Drug Resistance and its Biomarkers in High-Throughput Pharmacogenomic and CRISPR Screens: Interview With the Author
Dear All, The final programme for the In Silico Toxicology Network Meeting is now available,… Read More »In Silico Toxicology Network Meeting, 30 September 2020 – Final Programme & Job Board Online!
This list accompanies the In Silico Toxicology Network Meeting 2020 and will be updated until… Read More »(Computational) Toxicology Job Board
Emilie Henault, together with Maria Rasmussen and Jan Jensen at the University of Copenhagen, have… Read More »Chemical Space Exploration: How Genetic Algorithms Find the Needle in the Haystack. Interview with the Author
Dear All, I have just agreed to edit a special issue on ‘Artificial Intelligence for… Read More »Invitation: Special Issue on ‘Artificial Intelligence in Drug Discovery’ in Expert Opinion on Drug Discovery
Dear All, In particular due to some relevant upcoming events (and also new vacancies that… Read More »Cambridge Cheminformatics Newsletter, 6 July 2020
Dear All, Please find below recent news about events and vacancies in our area, as… Read More »Cambridge Cheminformatics Newsletter, 15 June 2020
Ines Smit is just about to finish her PhD at the University of Cambridge, where… Read More »Which ligand-protein activities cause adverse events? Interview with the author